Total Payments
$876.24
2022 Payments
$244.91
Companies
19
Transactions
43
Medicare Patients
920
Medicare Billing
$178,305
Payment Breakdown by Category
Food & Beverage$849.27 (96.9%)
Education$26.97 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $849.27 | 41 | 96.9% |
| Education | $26.97 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $179.54 | 7 | $0 (2022) |
| BIOTRONIK INC. | $74.25 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $68.93 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $62.96 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.71 | 3 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $56.99 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $48.37 | 3 | $0 (2022) |
| Amgen Inc. | $45.27 | 2 | $0 (2021) |
| ABBVIE INC. | $45.22 | 2 | $0 (2022) |
| Lilly USA, LLC | $42.26 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $244.91 | 10 | Novo Nordisk Inc ($105.72) |
| 2021 | $631.33 | 33 | BIOTRONIK INC. ($74.25) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: PRIMARY CARE | ||||||
| 05/19/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $75.59 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 03/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Diabetes Care | ||||||
| 03/23/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 01/19/2022 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 12/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 12/08/2021 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, VERQUVO | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular | ||||||
| 08/18/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
| 07/16/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: DIABETES | ||||||
| 06/28/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, VERQUVO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Genetic Disease | ||||||
| 06/08/2021 | BIOTRONIK INC. | Solia (Device), Rivacor, Acticor | Education | In-kind items and services | $11.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, VERQUVO | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 379 | 1,105 | $165,810 | $102,970 |
| 2022 | 11 | 442 | 780 | $122,348 | $68,487 |
| 2021 | 3 | 56 | 58 | $11,332 | $3,940 |
| 2020 | 2 | 43 | 66 | $12,730 | $2,909 |
Total Patients
920
Total Services
2,009
Medicare Billing
$178,305
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 146 | 817 | $114,490 | $70,163 | 61.3% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 46 | 81 | $16,200 | $10,933 | 67.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 41 | $11,360 | $8,352 | 73.5% |
| 99345 | Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes | Office | 2023 | 71 | 71 | $14,910 | $8,183 | 54.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 48 | 54 | $5,970 | $3,523 | 59.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 29 | $1,740 | $1,141 | 65.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,140 | $675.68 | 59.3% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 76 | 239 | $33,460 | $22,375 | 66.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 66 | 175 | $22,555 | $12,053 | 53.4% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 41 | 88 | $17,610 | $11,534 | 65.5% |
| 99345 | New patient home visit, typically 75 minutes | Office | 2022 | 75 | 75 | $15,750 | $10,943 | 69.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 19 | $5,285 | $4,035 | 76.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 64 | $13,184 | $3,572 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 35 | $10,640 | $2,036 | 19.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 19 | 23 | $1,380 | $934.25 | 67.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 12 | 12 | $1,140 | $744.28 | 65.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,072 | $160.42 | 15.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 34 | $272.00 | $98.70 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 22 | $6,688 | $2,283 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 22 | $4,532 | $1,615 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 14 | $112.00 | $42.00 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 44 | $9,410 | $2,135 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 22 | $3,320 | $773.99 | 23.3% |
About Olga Varnacheva, NP
Olga Varnacheva, NP is a Primary Care healthcare provider based in Gaithersburg, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952815771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olga Varnacheva, NP has received a total of $876.24 in payments from pharmaceutical and medical device companies, with $244.91 received in 2022. These payments were reported across 43 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($849.27).
As a Medicare-enrolled provider, Varnacheva has provided services to 920 Medicare beneficiaries, totaling 2,009 services with total Medicare billing of $178,305. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Gaithersburg, MD
- Active Since 12/01/2017
- Last Updated 02/20/2023
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1952815771
Products in Payments
- Rybelsus (Drug) $105.72
- Ozempic (Drug) $73.82
- XARELTO (Drug) $68.93
- JARDIANCE (Drug) $62.71
- Edora (Device) $62.62
- UPTRAVI (Drug) $56.99
- Repatha (Biological) $45.27
- TRULICITY (Drug) $42.26
- JANUVIA (Drug) $37.86
- BRILINTA (Drug) $29.67
- NURTEC ODT (Drug) $25.02
- FREESTYLE LIBRE 2 (Device) $24.76
- VRAYLAR (Drug) $24.01
- ONPATTRO (Drug) $22.15
- UBRELVY (Drug) $21.21
- SOLIQUA 100/33 (Biological) $20.12
- FARXIGA (Drug) $18.70
- GRALISE (Drug) $17.87
- UNITHROID (Drug) $17.33
- TOUJEO (Biological) $17.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.